drugset / Trial / NCT01923584
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of EPI-743 in patients with Parkinson's disease.
Timeline
- Start
- 2013-09
- Primary completion
- 2015-12
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vatiquinone | Small molecule | 200 mg | — |
| Comparator | Vatiquinone | Small molecule | 400 mg | — |